Transfusion guidelines regarding platelet-count thresholds before the placement of a central venous catheter (CVC) offer conflicting recommendations because of a lack of good-quality evidence. The ...
A group of 12 thrombocytopenic patients, ranging in age from two to fourteen years, were studied. The thrombocytopenia was due to diverse conditions (Table 1). The platelet count ranged from 3000 to ...
OBJECTIVE: To determine the most effective, evidence-based approach to the use of platelet transfusions in patients with cancer. OUTCOMES: Outcomes of interest included prevention of morbidity and ...
Platelet transfusion thresholds in according bleeding risk and the presence of bleeding. WHO = World Health Organization. “In practice, we see all too often [that] prophylactic transfusion of ...
65.4% of hospitalized ITP inpatients did not have a bleeding episode or surgical procedure associated with their platelet transfusion. Platelet transfusions were not associated with improved clinical ...
Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up. Seventy-eight patients undergoing induction therapy for acute leukemia were randomized to receive ...
Promacta tended to boost platelet counts in patients with low-risk MDS, and helped those patients be independent of transfusions, too. Promacta (eltrombopag) improved platelet counts in patients with ...
Platelet transfusions play a major role in the management of thrombocytopenia in hematological and oncologic patients. However, a proportion of these patients become refractory to the transfusion of ...
A new method for treating and chilling blood platelets may prolong their shelf-life by a week or more, helping to ease chronic shortages that endanger patients needing platelet transfusions. A new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results